Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?
Which of the following is Iso-osmolar agent?
Which of the following investigations is contraindicated in patients with metallic foreign body?
Which of the following is a nonionic dye used in medical imaging?
Which of the following statements about contrast in radiography is true:
Serum sickness is mediated by which type of hypersensitivity?
Which contrast agent is not used for CT scans?
Which of the following is a non-ionic contrast agent?
All of the following dyes are water soluble except:
With reference to lepromin test, which one of the following statements is correct?
Explanation: ***Iso-osmolar contrast*** - **Iso-osmolar contrast agents** (e.g., iodixanol) have an osmolality of ~290 mOsm/kg, which is identical to that of plasma. - **This is the PREFERRED choice** in patients with renal dysfunction as multiple studies demonstrate the lowest risk of contrast-induced nephropathy (CIN). - The iso-osmolar formulation minimizes osmotic stress on renal tubules and reduces the risk of acute kidney injury. - **Current guidelines recommend iso-osmolar agents as first-line** in high-risk patients with pre-existing renal impairment. *Low osmolar contrast* - **Low osmolar contrast agents** have osmolality of 600-900 mOsm/kg, which is significantly lower than high osmolar agents but still 2-3 times higher than plasma. - While **acceptable and safer than high osmolar agents**, they are not as optimal as iso-osmolar contrast for patients with renal dysfunction. - These agents are widely used and represent a reasonable alternative when iso-osmolar agents are not available. *High osmolar contrast* - **High osmolar contrast agents** have osmolality >1400 mOsm/kg (about 5 times that of plasma). - They carry the **highest risk of contrast-induced nephropathy** due to severe osmotic load and direct tubular toxicity. - **Contraindicated or strongly avoided** in patients with pre-existing renal dysfunction. *Ionic contrast* - **Ionic contrast** refers to the chemical structure (dissociates into ions) rather than osmolality. - Can be either high or low osmolar—the ionic nature alone does not determine renal safety. - The critical factor for nephrotoxicity prevention is osmolality, not ionic charge.
Explanation: ***Non-ionic Dimer contrast media*** - **Iodixanol** is the only available non-ionic dimer contrast agent, and it is **iso-osmolar** with blood plasma (290 mOsm/kg). - Its iso-osmolality contributes to a lower incidence of adverse reactions, particularly in patients at high risk. *Ionic Monomer - High osmolality contrast media* - These agents have an osmolality significantly higher than that of blood plasma, often 6-8 times greater. - High osmolality leads to a higher incidence of adverse effects due to cellular fluid shifts and direct endothelial damage. *Non-ionic Monomer - Low osmolality contrast media* - These agents have an osmolality lower than ionic monomers but are still hyperosmolar compared to blood plasma (typically 2-3 times higher). - While generally safer than high-osmolality agents, they can still cause discomfort and adverse reactions due to their hyperosmolality. *Ionic Dimer - Low osmolality contrast media* - Ionic dimers, such as **ioxaglate**, are considered low-osmolality agents but are still hyperosmolar relative to plasma. - They feature two benzene rings with iodine atoms and are salts, contributing to their osmolality.
Explanation: ***MRI*** - Magnetic resonance imaging (MRI) uses a powerful **magnetic field** and radio waves to create detailed images of organs and tissues. - The strong magnetic field can cause **ferromagnetic metallic objects** to move, heat up, or malfunction, posing a significant safety risk. *CT Scan* - A CT scan uses **X-rays** to produce cross-sectional images of the body and is generally safe in the presence of metallic foreign bodies. - While metallic objects can cause **artifacts** (streaks or distortions) in CT images, this does not pose a direct safety risk to the patient. *VER* - **Visual Evoked Response (VER)**, also known as VEP (Visual Evoked Potential), is an electrophysiological test that measures the electrical activity of the brain in response to visual stimuli. - It does not involve strong magnetic fields or radiation and is therefore **safe** for patients with metallic foreign bodies. *ERG* - An **Electroretinogram (ERG)** measures the electrical responses of the retina to light stimulation, assessing retinal function. - It is a non-invasive test that does not use magnetic fields or X-rays and is **not contraindicated** in the presence of metallic foreign bodies.
Explanation: ***Iohexol*** - **Iohexol** is a widely used **nonionic, low-osmolality contrast medium** in various medical imaging procedures. - Nonionic contrast agents generally have a **lower incidence of adverse reactions** compared to ionic agents due to their reduced osmolality. *Iothalamate* - **Iothalamate** is an **ionic, high-osmolality contrast medium**. - High-osmolality ionic agents are associated with a **higher risk of adverse events**, such as anaphylactoid reactions and nephrotoxicity. *Ioxaglate* - **Ioxaglate** is an **ionic dimer**, often described as a "monoacidic dimer," which gives it **lower osmolality** than traditional ionic monomers, but it is still fundamentally ionic. - While it has a better safety profile than older ionic monomers, it still differs structurally and functionally from true nonionic agents like iohexol. *None of the options* - This option is incorrect because **Iohexol** is indeed a nonionic dye used in medical imaging, fitting the description.
Explanation: ***Ionic monomers have three iodine atoms per two particles in solution*** - **Ionic monomeric contrast agents** (e.g., diatrizoate, iothalamate) dissociate in solution, producing **two particles** (one cation and one anion containing three iodine atoms) per molecule. - This dissociation results in a **high osmolality** compared to non-ionic agents, as osmolality is determined by the number of particles in solution. *Gadolinium cannot cross an intact blood brain barrier* - This statement is **FALSE** - **Gadolinium-based contrast agents CAN cross the blood-brain barrier when it is compromised**. - They are used in MRI precisely because they extravasate into tissues where the **blood-brain barrier is disrupted**, such as in tumors, inflammation, or infections. - However, they do **not cross an intact BBB** due to their size and hydrophilicity. *Iohexol is a high osmolar contrast media* - **Iohexol** is a **non-ionic, low osmolality contrast medium** (LOCM). - Its non-ionic nature means it does not dissociate in solution, leading to a significantly lower osmolality compared to older ionic agents. *Non-ionic contrast agents are always high osmolar* - **Non-ionic contrast agents** are characterized by their molecular structure which **does not dissociate into ions** in solution. - This property makes them **low osmolar** or **iso-osmolar**, meaning they have fewer particles in solution compared to ionic agents, thereby reducing osmolality.
Explanation: ***Type III*** - Serum sickness is a classic example of a **Type III hypersensitivity reaction**, characterized by the formation of **immune complexes** [1], [2]. - These immune complexes deposit in various tissues (e.g., blood vessels, joints, kidneys), leading to inflammation and tissue damage [3]. *Type II* - **Type II hypersensitivity** involves antibodies (IgG or IgM) binding directly to antigens on the surface of cells or in the extracellular matrix, leading to cell lysis or dysfunction. - Examples include **hemolytic transfusion reactions** or autoimmune hemolytic anemia, which are distinct from serum sickness. *Type IV* - **Type IV hypersensitivity** is a **delayed-type hypersensitivity (DTH)** reaction mediated by T cells rather than antibodies. - It typically manifests 24-72 hours after antigen exposure and is seen in conditions like **contact dermatitis** or tuberculosis skin tests. *Type I* - **Type I hypersensitivity** is an immediate reaction mediated by **IgE antibodies** binding to mast cells and basophils, leading to the release of inflammatory mediators upon re-exposure to an allergen. - Examples include **anaphylaxis** or allergic rhinitis, which have a rapid onset and different underlying mechanisms compared to serum sickness. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 214-215. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 172-173. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 215-216.
Explanation: ***CO2*** - **CO2** (carbon dioxide) is **not used as a contrast agent in CT scans**. - CO2 is primarily used in **angiography** (especially for peripheral vessels in patients with iodine allergy or renal insufficiency) where it acts as a negative contrast agent. - In CT, CO2 would appear as air/gas density and create artifacts rather than providing diagnostic enhancement, making it unsuitable for routine CT imaging. *Iodinated high-osmolality contrast media* - These are **iodinated contrast agents** that contain iodine atoms which strongly attenuate X-rays, making them highly effective for **CT imaging**. - High-osmolality contrast media (HOCM) like **diatrizoate** and **iothalamate** were the standard CT contrast agents historically. - They have largely been replaced by **low-osmolality** and **iso-osmolality** agents due to higher incidence of **adverse reactions**, but they are still used for CT scans. *Barium compounds* - **Barium sulfate** suspensions are widely used as **oral or rectal contrast agents** for CT imaging of the gastrointestinal tract. - Barium has high atomic number and effectively attenuates X-rays, making the **GI lumen clearly visible** on CT scans. - Used in **CT enterography**, **CT colonography**, and routine **abdominal/pelvic CT** protocols. *Gadolinium-based contrast agents* - **Gadolinium-based contrast agents (GBCAs)** are primarily designed for **MRI** due to their **paramagnetic properties**. - However, gadolinium DOES attenuate X-rays and can be used **off-label for CT** in patients with **severe iodine allergy** or **contraindications to iodinated contrast**. - While less effective than iodinated agents for CT (requiring higher doses), gadolinium-enhanced CT is a recognized alternative in special clinical circumstances.
Explanation: ***Iohexol*** - **Iohexol** is a well-known example of a **non-ionic, low osmolar contrast agent**. It's widely used due to its lower incidence of adverse reactions compared to ionic agents. - Non-ionic contrast agents remain as **intact molecules** in solution and do not dissociate into charged ions, contributing to their lower osmolality and better tolerability. *Amidotrizoate* - **Amidotrizoate** (also known as diatrizoate) is an **ionic, high osmolar contrast agent**. It dissociates into two ions in solution. - Due to its high osmolality, it is associated with a higher risk of adverse effects, such as **nausea**, **vomiting**, and **nephrotoxicity**. *Iothalamate* - **Iothalamate** is another example of an **ionic, high osmolar contrast agent**. It also dissociates into charged ions when dissolved. - Its use has decreased significantly with the development of safer non-ionic alternatives due to its higher potential for **adverse drug reactions**. *Ioxoglate* - **Ioxoglate** is a **dimeric, ionic contrast agent**. Although it's ionic, it has a lower osmolality than monomeric ionic agents due to its dimeric structure. - Despite being dimeric, it still dissociates into ions, distinguishing it from truly non-ionic compounds like iohexol.
Explanation: ***Myodil*** - **Myodil** (Iophendylate) is an **oil-based** contrast medium previously used for myelography. - Due to its **oil-based nature**, it is not water-soluble and had to be removed after the procedure to prevent complications. *Iohexol* - **Iohexol** is a **non-ionic, water-soluble** contrast agent commonly used in various radiological procedures, including myelography. - Its water solubility allows for easy absorption and excretion from the body. *Conray 420* - **Conray 420** (Iothalamate meglumine) is an **ionic, water-soluble** contrast agent often used for angiography and urography. - It readily mixes with bodily fluids due to its water-soluble properties. *Metrizamide* - **Metrizamide** was an early **non-ionic, water-soluble** contrast agent specifically developed for myelography. - Although water-soluble, it had a higher incidence of neurotoxicity compared to newer agents like iohexol.
Explanation: ***Lepromin test is strongly positive in tuberculoid leprosy*** - In **tuberculoid leprosy**, the immune system mounts a strong cell-mediated response against *Mycobacterium leprae*, leading to a strongly positive lepromin reaction. - A positive lepromin test indicates a good host immune response and is associated with the **paucibacillary** forms of the disease. *It can be used as a diagnostic test* - The lepromin test is not a diagnostic tool for leprosy; it primarily assesses the host's **cell-mediated immunity** to *Mycobacterium leprae* antigens. - Diagnosis of leprosy relies on **clinical signs**, **skin smears** for acid-fast bacilli, and histopathological examination, not the lepromin test. *Its interpretation is done within 24 hours* - The lepromin test interpretation involves two phases: the **Fernandez reaction** (early reaction at 24-48 hours) and the **Mitsuda reaction** (late reaction at 3-4 weeks). - The most significant and commonly referred result, the **Mitsuda reaction**, is read at **3 to 4 weeks** after injection. *It is not affected by BCG vaccine* - The **BCG vaccine**, which is used to prevent tuberculosis, can induce some cross-reactivity and lead to a positive lepromin test in individuals who have received it. - This cross-reactivity can sometimes confound the interpretation of the lepromin test, as both mycobacteria share common antigens.
Get full access to all questions, explanations, and performance tracking.
Start For Free